Research and Development

Sanofi has reinforced its senior staff with a double-whammy of appointments; firstly, the French firm has announced that it is …

Medherant has brought in Dr Ken Cunningham as Chair in a bid to strengthen the company as it moves into …

As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new …

Research coming out of The Institute of Cancer Research, and funded by charity Bloodwise, has found that people who inherit …

Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …

The figures emerging from research conducted by Cancer Research UK predict that rates of cancer in women will rise by …

Moving into February,and the first weeks of Trump’s term, the US President has dominated the headlines in the industry as …

With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …

Cirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending …

The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …

2016 was characterised by some of the biggest political shifts in recent times. We ask four major pharma figures for …

Recent research has been published that reveals that a four kilometre stretch of coastline in China harboured bacteria resistant to …

Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …

Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …

Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …